Publication Date:
1995-06-02
Description:
Genetic manipulation of malaria parasites would revolutionize the study of this group of pathogens and have implications for vaccine and drug development. This report describes the stable, drug-selectable genetic transformation of the clinically relevant intracellular blood stages of a malaria parasite. A plasmid transfection vector carrying the gene locus that encodes a drug-resistant form of the bifunctional enzyme dihydrofolate reductase-thymidylate synthase from the rodent malaria parasite Plasmodium berghei was constructed. Derivatives of this vector were introduced into merozoites of P. berghei by electroporation, and parasites were selected for successful transformation in the rodent host on the basis of resistance to pyrimethamine. The plasmids were present in a circular, unrearranged form that replicated episomally to an observed maximum of 15 copies per cell in drug-resistant populations.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉van Dijk, M R -- Waters, A P -- Janse, C J -- New York, N.Y. -- Science. 1995 Jun 2;268(5215):1358-62.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Parasitology, University of Leiden, Netherlands.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7761856" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Base Sequence
;
DNA Replication
;
Drug Resistance
;
Electroporation
;
Erythrocytes/parasitology
;
Genes, Protozoan
;
Genetic Vectors
;
Molecular Sequence Data
;
Multienzyme Complexes/*genetics
;
Plasmids
;
Plasmodium berghei/drug effects/*genetics/growth & development
;
Point Mutation
;
Pyrimethamine/*pharmacology
;
Rats
;
Rats, Wistar
;
Replication Origin
;
Tetrahydrofolate Dehydrogenase/*genetics
;
Thymidylate Synthase/*genetics
;
*Transfection
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink